Somatic SF3B1 hotspot mutation in prolactinomas
The genetic basis of prolactinomas remains poorly understood. Here, the authors find a recurrent hotspot somatic mutation in the splicing factor 3 subunit B1 (SF3B1 R625H ) in prolactinomas, and show that this mutation causes aberrant splicing of ESRRG mRNA leading to up-regulation of prolactin.
Guardado en:
Autores principales: | Chuzhong Li, Weiyan Xie, Jared S. Rosenblum, Jianyu Zhou, Jing Guo, Yazhou Miao, Yutao Shen, Hongyun Wang, Lei Gong, Mingxuan Li, Sida Zhao, Sen Cheng, Haibo Zhu, Tao Jiang, Shiying Ling, Fei Wang, Hongwei Zhang, Mingshan Zhang, Yanming Qu, Qi Zhang, Guilin Li, Junmei Wang, Jun Ma, Zhengping Zhuang, Yazhuo Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/03819aa8e3fa4e1cb3bc7de1641abf1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phosphorylation of Pit-1 by cyclin-dependent kinase 5 at serine 126 is associated with cell proliferation and poor prognosis in prolactinomas
por: Xie Weiyan, et al.
Publicado: (2021) -
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
por: Shuman Wang, et al.
Publicado: (2021) -
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
por: Yunzhi Zou, et al.
Publicado: (2021) -
Hotspots, flaws and deficiencies of research on rural energy upgrading: A review
por: Jiashi Han, et al.
Publicado: (2021) -
Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas
por: Lukas Andereggen, et al.
Publicado: (2021)